Primary cancer prevention trials

Citation
Et. Hawk et Sm. Lippman, Primary cancer prevention trials, HEMAT ONCOL, 14(4), 2000, pp. 809
Citations number
109
Language
INGLESE
art.tipo
Review
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
ISSN journal
0889-8588 → ACNP
Volume
14
Issue
4
Year of publication
2000
Database
ISI
SICI code
0889-8588(200008)14:4<809:PCPT>2.0.ZU;2-E
Abstract
Cancer, formerly considered a clinically catastrophic event, is but one lat e stage in a long disease process driven by cumulative molecular alteration s that affect genomic integrity and control of cellular identity and growth . improved understanding of this process has led to opportunities for earli er intervention, thereby preventing invasive cancers. Approval of an agent for breast cancer risk reduction has raised professional and public expecta tions for preventive oncology and fostered excitement in this rapidly growi ng field. This article examines the current status of, and future prospects for, the science and practice of cancer chemoprevention.